COMPANY

Surgisense Corporation

HQ: Bethesda, MD source · surgisense.com ↗ · Mid-Atlantic

Location: Bethesda, MD · source · Oct 14, 2026

Profile checked Oct 10, 2026

NIH awards 6

Annual award amounts. Total $4.1M.

Feb 23, 2016 NIH award 5R44CA192460-02 FY2016: $927,780 awarded for that fiscal year; activity R44 (SBIR); PI ZAND, JASON MATTHEW; recipient as written: SURGISENSE CORPORATION, Bethesda, MD. Oxygen Mapping System for Enhanced Col source ↗
Mar 11, 2015 NIH award 1R44CA192460-01 FY2015: $1,072,220 awarded for that fiscal year; activity R44 (SBIR); PI ZAND, JASON MATTHEW; recipient as written: SURGISENSE CORPORATION, Bethesda, MD. Oxygen Mapping System for Enhanced C source ↗
Apr 25, 2013 NIH award 5R44CA153571-03 FY2013: $837,727 awarded for that fiscal year; activity R44 (SBIR); PI ZAND, JASON MATTHEW; recipient as written: SURGISENSE CORPORATION, Bethesda, MD. Device to Improve Treatment of Colorec source ↗
Jun 1, 2012 NIH award 2R44CA153571-02 FY2012: $879,262 awarded for that fiscal year; activity R44 (SBIR); PI ZAND, JASON MATTHEW; recipient as written: SURGISENSE CORPORATION, Bethesda, MD. Device to Improve Treatment of Colorec source ↗
Sep 13, 2010 NIH award 1R43CA153571-01A1 FY2010: $228,501 awarded for that fiscal year; activity R43 (SBIR); PI ZAND, JASON MATTHEW; recipient as written: SURGISENSE CORPORATION, Bethesda, MD. Device to Improve Treatment of Color source ↗
Jul 10, 2009 NIH award 1R43CA137954-01A2 FY2009: $199,385 awarded for that fiscal year; activity R43 (SBIR); PI ZAND, JASON MATTHEW; recipient as written: SURGISENSE CORPORATION, Bethesda, MD. A Device to Reduce Anastomotic Failu source ↗